CytochromeP450 2D6 and Atomoxetine Metabolism
References
- ter Laak MA Temmink AH Koeken A van ’t Veer NE van Hattum PR Cobbaert CM Recognition of impaired atomoxetine metabolism because of low CYP2D6 activity Pediatr Neurol 2010 Sep 43 3 159 62 10.1016/j.pediatrneurol.2010.04.004 20691935
DOI: https://doi.org/10.15844/pedneurbriefs-24-10-1 | Journal eISSN: 2166-6482
Language: English
Page range: 73 - 74
Published on: Oct 1, 2010
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 2010 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.